CHILTERN
CHILTERN INTERNATIONAL
HOME | NEWS | EVENTS | PUBLICATIONS | USEFUL LINKS | CAREERS | CONTACT US
Clinical Trials
FIRST IN MAN PHOTOTOXICITY PHASE I-IIa

  Get Paid in Participating in Clinical Trials
ABOUT Chiltern (Early Phase) Ltd. (CEP)

Chiltern (Early Phase) Ltd. (CEP), formerly Drug Development Solutions, is one of the oldest UK-based Contract Research Organizations. We specialize in Phase I clinical trials, especially in First-In-Man and Phototoxicity studies.

During the past 25 years, we have performed over 700 studies, covering a wide range of pharmacokinetic and pharmacodynamic studies in all the major therapeutic areas.

We are located in Dundee, Scotland where we occupy a purpose built, 42-bed research unit in Ninewells Hospital, one of the largest hospital complexes in Europe. This location provides access to a large patient population for Phase IIa efficacy studies (e.g. renal and hepatic impairment patients).

Our commitment to quality is shown through our GMP and ISO 9001:2000 accreditation, and we have been ICH GCP inspected by the MHRA. CEP also provides data management, medical writing and regulatory support.

We can tailor our work to your requirements and have significant experience in supplying data to the regulatory authorities in Japan, the USA and the EU.


SELECT YOUR REGION

FOR MORE INFORMATION PLEASE SELECT YOUR REGION OR BROWSE OUR SERVICES FROM THE LINKS ON THE LEFT:

USA
EUROPE
JAPAN/ASIA
ROW
Print This Page | Disclaimer